Related Experiment Videos

Pericardial disease and human immunodeficiency virus in Dar es Salaam, Tanzania

J P Cegielski1, K Ramiya, G J Lallinger

  • 1Division of Infectious Diseases and International Health, Duke University Medical Center, Durham, North Carolina 27710.

Lancet (London, England)
|January 27, 1990
PubMed

The number of patients admitted to Muhimbili Medical Centre, Tanzania, with pericardial effusions rose after the epidemic of acquired immunodeficiency syndrome (AIDS) began. To investigate a possible relation all patients with suspected pericardial disease admitted between Oct 1, 1987, and March 31, 1989, were studied. 28 of 42 patients (67%) were seropositive for human immunodeficiency virus (HIV). 28 of 39 patients (72%) with pericardial effusion were HIV-seropositive compared with 0 of 3 without effusion. More HIV-seronegative than HIV-seropositive patients were receiving antituberculous chemotherapy and had ascites at enrollment. Only 5 of 28 HIV-seropositive patients had clinical signs of AIDS. 9 of 14 HIV-seropositive patients tested had positive Mantoux tests. There were no significant differences between the HIV-seropositive and seronegative groups in the duration of symptoms, laboratory results, X-ray or ultrasound findings, frequency of tamponade, or mortality. 38 patients were treated for tuberculosis. Pericardial effusion is strongly associated with, and an early manifestation of, HIV infection in Tanzania.

Related Concept Videos